Telemedicine in reproductive medicine—implications for technology and clinical practice

In this month’s Views and Reviews, the technological requirements for telemedicine and the current and future use of remote visits are discussed.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment
Related Content

VOLUME 114, ISSUE 6, P1125

Author:

Mark Sigman, M.D.

Abstract:

The COVID-19 pandemic has caused the rapid adoption of telemedicine in most medical practices. This series of articles address issues that are often not well considered, such as the types of technological platforms available, the effects of telemedicine on staffing, space requirements, and the financial impact of remote visits. In addition, the limits of telemedicine compared to in-office visits are discussed, as well as the effects on trainees and possibilities for the future.
Read the full text here. 
Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.